Informe de análisis de tamaño y pronóstico del mercado de nutrición enteral en Europa (2021-2031), participación regional, tendencias y oportunidades de crecimiento Cobertura: por tipo de producto (nasogástrico, nasoenteral, para sorbos y otros) y país
Formulaciones estandarizadas y productos de nutrición a base de plantas
Existe un aumento en la demanda de productos que ayuden a los consumidores a gestionar de forma proactiva su salud, especialmente aquellos centrados en necesidades específicas en términos de niveles de energía, inmunidad y tratamiento de enfermedades. La funcionalidad y las formulaciones específicas de los productos enterales no interfieren con los tratamientos existentes de los pacientes. Las formulaciones de macronutrientes y micronutrientes de la nutrición enteral y sus aplicaciones varían en función de la enfermedad en cuestión. Las fórmulas de nutrición enteral isocalórica (1 kcal/ml) se prescriben generalmente para alcanzar objetivos calóricos estimados o medidos, mientras que las fórmulas con alto contenido energético (>1 kcal/ml) se prescriben para aumentar el aporte calórico en pacientes con disfunción gastrointestinal.
Los productos de nutrición enteral estandarizados contienen componentes fijos y están diseñados para satisfacer los requerimientos nutricionales promedio de los pacientes, considerando que los requerimientos difieren en diferentes grupos de edad. Por ejemplo, Peptamen Formula (Nestlé) es la única fórmula basada en péptidos con proteína de suero 100% hidrolizada enzimáticamente que ayuda a superar la intolerancia a la alimentación por sonda. Estas fórmulas de alimentación por sonda son productos de nutrición enteral especializados diseñados para apoyar la absorción y superar los mecanismos de tolerancia en individuos con trastornos gastrointestinales.
Un aumento en la cantidad de personas que recurren a alimentos de origen vegetal desencadena la demanda de productos de nutrición de origen vegetal en todo el mundo. Las personas se están volviendo cada vez más intolerantes a los ingredientes de origen artificial/sintético utilizados en mayores cantidades, lo que puede provocar reacciones adversas. La encuesta de consumidores Innova 2020 mostró que la salud, la variedad de la dieta, la sostenibilidad y el sabor se encuentran entre las principales razones por las que las personas consideran las alternativas basadas en plantas. Abbott afirma que los consumidores y los pacientes que dependen de la alimentación por sonda también prestan mucha atención a estos parámetros. Las empresas del mercado europeo de nutrición enteral están aprovechando la creciente preferencia por los alimentos saludables en varios grupos demográficos. Como resultado, empresas como Kate Farms, Functional Formularies y Real Food Blends han desarrollado productos enterales más naturales y de origen vegetal. En agosto de 2021, Kate Farms lanzó el primer sistema de alimentación cerrado que ofrece fórmulas de origen vegetal en bolsas listas para colgar de 1 L de capacidad. Las fórmulas Kate Farms Standard 1.4 plain y Peptide 1.5 plain son productos de origen vegetal, orgánicos y densos en calorías que se utilizan como única fuente de nutrición complementaria en la alimentación por sonda. En septiembre de 2021, Abbott presentó una cartera de proteínas de origen vegetal e ingredientes alimentarios orgánicos para niños y adultos.
Por lo tanto, las formulaciones funcionales centradas en el paciente y los productos nutricionales a base de plantas son las principales tendencias emergentes en el mercado de nutrición enteral en Europa.
Análisis del mercado de nutrición enteral en Francia
Según un artículo de Le Monde publicado en marzo de 2023, se espera que la proporción de personas de 60 años o más en Francia aumente de ~20% en 2023 a ~30% en 2050. El número de personas de 85 años o más crecería casi un 90% durante 2030-2050. Los adultos mayores a menudo padecen enfermedades crónicas como diabetes, enfermedades cardiovasculares y trastornos neurológicos (por ejemplo, accidente cerebrovascular, enfermedad de Parkinson y Alzheimer). Estas afecciones pueden afectar la capacidad de comer normalmente, lo que lleva a la desnutrición y requiere alimentación enteral. Según el Observatorio Mundial del Cáncer, Francia notificó 483.568 nuevos casos de cáncer en 2022, y el número de casos prevalentes (quinquenales) fue de 1.494.814. El cáncer y la nutrición enteral están estrechamente relacionados. Muchos pacientes con cáncer sufren desnutrición debido a la propia enfermedad o a los tratamientos que reciben, lo que puede afectar su capacidad para comer y absorber nutrientes esenciales.
Fresenius Kabir France ofrece una cartera diversa de productos de nutrición enteral listos para usar, como alimentos por sonda, suplementos nutricionales orales (ONS) y productos en polvo. Para los pacientes con disfagia, la empresa ofrece productos de textura modificada en diferentes consistencias para satisfacer las necesidades individuales de los diferentes pacientes.
Análisis de segmentación del informe del mercado de nutrición enteral en Europa
Los segmentos clave que contribuyeron a la derivación del análisis del mercado de nutrición enteral en Europa son el tipo, el material y el usuario final.
Según el tipo de producto, el mercado de nutrición enteral en Europa se segmenta en Nasogástrico, Nasoenteral, Sipping y Otros. El segmento nasogástrico tuvo la mayor participación del mercado en 2023.
Algunos actores destacados que operan en el mercado de nutrición enteral en Europa son Nestlé, Danone SA, Abbott Laboratories, Friesland Campina, Fresenius SE and Co. KGaA, B. Braun SE, Dr. Schär AG, Arla Food, Reckitt Benckiser, Perrigo Company PLC, Fonterra Co-operative Group Limited, Kate Farms y Nutritional Medicinals, LLC, entre otros.
Las empresas están lanzando productos y servicios nuevos e innovadores para mantener su posición en el tamaño del mercado de nutrición enteral en Europa. En noviembre de 2021, Abbott lanzó Similac 360 Total Care para apoyar el sistema inmunológico, la salud digestiva y el desarrollo cerebral. Similac 360 Total Care es la primera y única fórmula infantil en los EE. UU. con una mezcla de cinco HMO diferentes, que anteriormente solo se encontraban juntos en la leche materna. Esta fórmula está diseñada para brindar nutrición que favorezca la salud y el desarrollo de todo el bebé, incluido el sistema inmunológico en desarrollo, el sistema digestivo y el cerebro.
1. Introduction
1.1 The Insight Partners Research Report Guidance
1.2 Market Segmentation
2. Executive Summary
2.1 Key Insights
3. Research Methodology
3.1 Secondary Research
3.2 Primary Research
3.2.1 Hypothesis formulation:
3.2.2 Macro-economic factor analysis:
3.2.3 Developing base number:
3.2.4 Data Triangulation:
3.2.5 Country level data:
4. Europe Enteral Nutrition Market Landscape
4.1 Overview
4.2 PEST Analysis
4.3 Pricing Analysis
4.4 Pricing Analysis for Sipping Formula
4.5 List of Key Market Players in Top 5 Market
4.5.1 Major Market players in Germany, France, United Kingdom
5. Europe Enteral Nutrition Market – Key Market Dynamics
5.1 Europe Enteral Nutrition Market – Key Market Dynamics
5.2 Market Drivers
5.2.1 Increasing Prevalence of Gastrointestinal Diseases
5.2.2 Rising Cases of Malnutrition and Premature Births
5.3 Market Restraints
5.3.1 Mechanical, Gastrointestinal, and Metabolic Complications Associated with Feeding Systems
5.4 Market Opportunities
5.4.1 Strategic Initiatives by Key Market Players
5.5 Future Trends
5.5.1 Standardized Formulations and Plant-Based Nutrition Products
5.6 Impact of Drivers and Restraints:
6. Europe Enteral Nutrition Market Analysis
6.1 Europe Enteral Nutrition Market Revenue (US$ Million), 2021–2031
6.2 Europe Enteral Nutrition Market Forecast and Analysis
6.3 Enteral and Parenteral Market Value (%)
7. Europe Enteral Nutrition Market Analysis – by Product Type
7.1 Nasogastric
7.1.1 Overview
7.1.2 Nasogastric: Europe Enteral Nutrition Market – Revenue and Forecast to 2031 (US$ Million)
7.1.3 Standard
7.1.3.1 Overview
7.1.3.2 Standard: Europe Enteral Nutrition Market – Revenue and Forecast to 2031 (US$ Million)
7.1.4 Disease Specific
7.1.4.1 Overview
7.1.4.2 Disease Specific: Europe Enteral Nutrition Market – Revenue and Forecast to 2031 (US$ Million)
7.2 Nasoenteral
7.2.1 Overview
7.2.2 Nasoenteral: Europe Enteral Nutrition Market – Revenue and Forecast to 2031 (US$ Million)
7.3 Sipping
7.3.1 Overview
7.3.2 Sipping: Europe Enteral Nutrition Market – Revenue and Forecast to 2031 (US$ Million)
7.4 Others
7.4.1 Overview
7.4.2 Others: Europe Enteral Nutrition Market – Revenue and Forecast to 2031 (US$ Million)
8. Europe Enteral Nutrition Market – Country Analysis
8.1 Europe
8.1.1 Europe Enteral Nutrition Market Breakdown by Countries
8.1.2 Europe Enteral Nutrition Market Revenue and Forecast and Analysis – by Country
8.1.2.1 Europe Enteral Nutrition Market Revenue and Forecast and Analysis – by Country
8.1.2.2 Germany: Europe Enteral Nutrition Market – Revenue and Forecast to 2031 (US$ Million)
8.1.2.2.1 Germany: Europe Enteral Nutrition Market Breakdown by Product Type
8.1.2.2.2 Germany: Europe Enteral Nutrition Market Breakdown by Nasogastric Type
8.1.2.2.3 Germany: Europe Enteral Nutrition Market Breakdown by Standard By Calories
8.1.2.2.4 Germany: Europe Enteral Nutrition Market Breakdown by Isocaloric
8.1.2.2.5 Germany: Europe Enteral Nutrition Market Breakdown by Hypercaloric
8.1.2.2.6 Germany: Europe Enteral Nutrition Market Breakdown by Standard By Type
8.1.2.2.7 Germany: Europe Enteral Nutrition Market Breakdown by Standard By End User
8.1.2.3 United Kingdom: Europe Enteral Nutrition Market – Revenue and Forecast to 2031 (US$ Million)
8.1.2.3.1 United Kingdom: Europe Enteral Nutrition Market Breakdown by Product Type
8.1.2.3.2 United Kingdom: Europe Enteral Nutrition Market Breakdown by Nasogastric Type
8.1.2.3.3 United Kingdom: Europe Enteral Nutrition Market Breakdown by Standard By Calories
8.1.2.3.4 United Kingdom: Europe Enteral Nutrition Market Breakdown by Isocaloric
8.1.2.3.5 United Kingdom: Europe Enteral Nutrition Market Breakdown by Hypercaloric
8.1.2.3.6 United Kingdom: Europe Enteral Nutrition Market Breakdown by Standard By Type
8.1.2.3.7 United Kingdom: Europe Enteral Nutrition Market Breakdown by Standard By End User
8.1.2.4 France: Europe Enteral Nutrition Market – Revenue and Forecast to 2031 (US$ Million)
8.1.2.4.1 France: Europe Enteral Nutrition Market Breakdown by Product Type
8.1.2.4.2 France: Europe Enteral Nutrition Market Breakdown by Nasogastric Type
8.1.2.4.3 France: Europe Enteral Nutrition Market Breakdown by Standard By Calories
8.1.2.4.4 France: Europe Enteral Nutrition Market Breakdown by Isocaloric
8.1.2.4.5 France: Europe Enteral Nutrition Market Breakdown by Hypercaloric
8.1.2.4.6 France: Europe Enteral Nutrition Market Breakdown by Standard By Type
8.1.2.4.7 France: Europe Enteral Nutrition Market Breakdown by Standard By End User
8.1.2.5 Italy: Europe Enteral Nutrition Market – Revenue and Forecast to 2031 (US$ Million)
8.1.2.5.1 Italy: Europe Enteral Nutrition Market Breakdown by Product Type
8.1.2.5.2 Italy: Europe Enteral Nutrition Market Breakdown by Nasogastric Type
8.1.2.5.3 Italy: Europe Enteral Nutrition Market Breakdown by Standard By Calories
8.1.2.5.4 Italy: Europe Enteral Nutrition Market Breakdown by Isocaloric
8.1.2.5.5 Italy: Europe Enteral Nutrition Market Breakdown by Hypercaloric
8.1.2.5.6 Italy: Europe Enteral Nutrition Market Breakdown by Standard By Type
8.1.2.5.7 Italy: Europe Enteral Nutrition Market Breakdown by Standard By End User
8.1.2.6 Spain: Europe Enteral Nutrition Market – Revenue and Forecast to 2031 (US$ Million)
8.1.2.6.1 Spain: Europe Enteral Nutrition Market Breakdown by Product Type
8.1.2.6.2 Spain: Europe Enteral Nutrition Market Breakdown by Nasogastric Type
8.1.2.6.3 Spain: Europe Enteral Nutrition Market Breakdown by Standard By Calories
8.1.2.6.4 Spain: Europe Enteral Nutrition Market Breakdown by Isocaloric
8.1.2.6.5 Spain: Europe Enteral Nutrition Market Breakdown by Hypercaloric
8.1.2.6.6 Spain: Europe Enteral Nutrition Market Breakdown by Standard By Type
8.1.2.6.7 Spain: Europe Enteral Nutrition Market Breakdown by Standard By End User
8.1.2.7 Czech Republic: Europe Enteral Nutrition Market – Revenue and Forecast to 2031 (US$ Million)
8.1.2.7.1 Czech Republic: Europe Enteral Nutrition Market Breakdown by Product Type
8.1.2.7.2 Czech Republic: Europe Enteral Nutrition Market Breakdown by Nasogastric Type
8.1.2.7.3 Czech Republic: Europe Enteral Nutrition Market Breakdown by Standard By Calories
8.1.2.7.4 Czech Republic: Europe Enteral Nutrition Market Breakdown by Isocaloric
8.1.2.7.5 Czech Republic: Europe Enteral Nutrition Market Breakdown by Hypercaloric
8.1.2.7.6 Czech Republic: Europe Enteral Nutrition Market Breakdown by Standard By Type
8.1.2.7.7 Czech Republic: Europe Enteral Nutrition Market Breakdown by Standard By End User
8.1.2.8 Rest of Europe: Europe Enteral Nutrition Market – Revenue and Forecast to 2031 (US$ Million)
8.1.2.8.1 Rest of Europe: Europe Enteral Nutrition Market Breakdown by Product Type
8.1.2.8.2 Rest of Europe: Europe Enteral Nutrition Market Breakdown by Nasogastric Type
8.1.2.8.3 Rest of Europe: Europe Enteral Nutrition Market Breakdown by Standard By Calories
8.1.2.8.4 Rest of Europe: Europe Enteral Nutrition Market Breakdown by Isocaloric
8.1.2.8.5 Rest of Europe: Europe Enteral Nutrition Market Breakdown by Hypercaloric
8.1.2.8.6 Rest of Europe: Europe Enteral Nutrition Market Breakdown by Standard By Type
8.1.2.8.7 Rest of Europe: Europe Enteral Nutrition Market Breakdown by Standard By End User
9. Industry Landscape
9.1 Overview
9.2 Growth Strategies in Europe Enteral Nutrition Market
9.3 Organic Growth Strategies
9.3.1 Overview
9.4 Inorganic Growth Strategies
9.4.1 Overview
10. Company Profiles
10.1 Nestle SA
10.1.1 Key Facts
10.1.2 Business Description
10.1.3 Products and Services
10.1.4 Financial Overview
10.1.5 SWOT Analysis
10.1.6 Key Developments
10.2 Danone SA
10.2.1 Key Facts
10.2.2 Business Description
10.2.3 Products and Services
10.2.4 Financial Overview
10.2.5 SWOT Analysis
10.2.6 Key Developments
10.3 Abbott Laboratories
10.3.1 Key Facts
10.3.2 Business Description
10.3.3 Products and Services
10.3.4 Financial Overview
10.3.5 SWOT Analysis
10.3.6 Key Developments
10.4 Royal FrieslandCampina NV
10.4.1 Key Facts
10.4.2 Business Description
10.4.3 Products and Services
10.4.4 Financial Overview
10.4.5 SWOT Analysis
10.4.6 Key Developments
10.5 Fresenius SE & Co KGaA
10.5.1 Key Facts
10.5.2 Business Description
10.5.3 Products and Services
10.5.4 Financial Overview
10.5.5 SWOT Analysis
10.5.6 Key Developments
10.6 B Braun SE
10.6.1 Key Facts
10.6.2 Business Description
10.6.3 Products and Services
10.6.4 Financial Overview
10.6.5 SWOT Analysis
10.6.6 Key Developments
10.7 Reckitt Benckiser Group Plc
10.7.1 Key Facts
10.7.2 Business Description
10.7.3 Products and Services
10.7.4 Financial Overview
10.7.5 SWOT Analysis
10.7.6 Key Developments
10.8 Kate Farms Inc
10.8.1 Key Facts
10.8.2 Business Description
10.8.3 Products and Services
10.8.4 Financial Overview
10.8.5 SWOT Analysis
10.8.6 Key Developments
10.9 Dr Schar AG
10.9.1 Key Facts
10.9.2 Business Description
10.9.3 Products and Services
10.9.4 Financial Overview
10.9.5 SWOT Analysis
10.9.6 Key Developments
10.10 Fonterra Co-Operative Group Ltd
10.10.1 Key Facts
10.10.2 Business Description
10.10.3 Products and Services
10.10.4 Financial Overview
10.10.5 SWOT Analysis
10.10.6 Key Developments
10.11 Arla Foods amba
10.11.1 Key Facts
10.11.2 Business Description
10.11.3 Products and Services
10.11.4 Financial Overview
10.11.5 SWOT Analysis
10.11.6 Key Developments
10.12 Perrigo Co Plc
10.12.1 Key Facts
10.12.2 Business Description
10.12.3 Products and Services
10.12.4 Financial Overview
10.12.5 SWOT Analysis
10.12.6 Key Developments
10.13 Charing Cross Scientific AS
10.13.1 Key Facts
10.13.2 Business Description
10.13.3 Products and Services
10.13.4 Financial Overview
10.13.5 SWOT Analysis
10.13.6 Key Developments
10.14 Bexen Medical
10.14.1 Key Facts
10.14.2 Business Description
10.14.3 Products and Services
10.14.4 Financial Overview
10.14.5 SWOT Analysis
10.14.6 Key Developments
11. Appendix
11.1 About The Insight Partners
11.2 Glossary of Terms
List of Tables
Table 1. Europe Enteral Nutrition Market Segmentation
Table 2. Europe Enteral Nutrition Market – Revenue and Forecast to 2031 (US$ Million)
Table 3. Europe Enteral Nutrition Market – Revenue and Forecast to 2031 (US$ Million) – by Product Type
Table 4. Sipping: Europe Enteral Nutrition Market, By Type (US$ Mn)
Table 5. Sipping: Europe Enteral Nutrition Market, By Standadr by Calories (US$ Mn)
Table 6. Sipping: Europe Enteral Nutrition Market, By Isocaloric (US$ Mn)
Table 7. Sipping: Europe Enteral Nutrition Market, By Hypercaloric (US$ Mn)
Table 8. Sipping: Europe Enteral Nutrition Market, By Standard by Type (US$ Mn)
Table 9. Sipping: Europe Enteral Nutrition Market, By Standard End User (US$ Mn)
Table 10. Sipping: Top 5 Europe Enteral Nutrition Markets (US$ Mn)
Table 11. Europe Enteral Nutrition Market – Revenue and Forecast to 2031 (US$ Million) – by Country
Table 12. Germany: Europe Enteral Nutrition Market – Revenue and Forecast to 2031 (US$ Million) – by Product Type
Table 13. Germany: Europe Enteral Nutrition Market – Revenue and Forecast to 2031 (US$ Million) – by Nasogastric Type
Table 14. Germany: Europe Enteral Nutrition Market – Revenue and Forecast to 2031 (US$ Million) – by Standard By Calories
Table 15. Germany: Europe Enteral Nutrition Market – Revenue and Forecast to 2031 (US$ Million) – by Isocaloric
Table 16. Germany: Europe Enteral Nutrition Market – Revenue and Forecast to 2031 (US$ Million) – by Hypercaloric
Table 17. Germany: Europe Enteral Nutrition Market – Revenue and Forecast to 2031 (US$ Million) – by Standard By Type
Table 18. Germany: Europe Enteral Nutrition Market – Revenue and Forecast to 2031 (US$ Million) – by Standard By End User
Table 19. United Kingdom: Europe Enteral Nutrition Market – Revenue and Forecast to 2031 (US$ Million) – by Product Type
Table 20. United Kingdom: Europe Enteral Nutrition Market – Revenue and Forecast to 2031 (US$ Million) – by Nasogastric Type
Table 21. United Kingdom: Europe Enteral Nutrition Market – Revenue and Forecast to 2031 (US$ Million) – by Standard By Calories
Table 22. United Kingdom: Europe Enteral Nutrition Market – Revenue and Forecast to 2031 (US$ Million) – by Isocaloric
Table 23. United Kingdom: Europe Enteral Nutrition Market – Revenue and Forecast to 2031 (US$ Million) – by Hypercaloric
Table 24. United Kingdom: Europe Enteral Nutrition Market – Revenue and Forecast to 2031 (US$ Million) – by Standard By Type
Table 25. United Kingdom: Europe Enteral Nutrition Market – Revenue and Forecast to 2031 (US$ Million) – by Standard By End User
Table 26. France: Europe Enteral Nutrition Market – Revenue and Forecast to 2031 (US$ Million) – by Product Type
Table 27. France: Europe Enteral Nutrition Market – Revenue and Forecast to 2031 (US$ Million) – by Nasogastric Type
Table 28. France: Europe Enteral Nutrition Market – Revenue and Forecast to 2031 (US$ Million) – by Standard By Calories
Table 29. France: Europe Enteral Nutrition Market – Revenue and Forecast to 2031 (US$ Million) – by Isocaloric
Table 30. France: Europe Enteral Nutrition Market – Revenue and Forecast to 2031 (US$ Million) – by Hypercaloric
Table 31. France: Europe Enteral Nutrition Market – Revenue and Forecast to 2031 (US$ Million) – by Standard By Type
Table 32. France: Europe Enteral Nutrition Market – Revenue and Forecast to 2031 (US$ Million) – by Standard By End User
Table 33. Italy: Europe Enteral Nutrition Market – Revenue and Forecast to 2031 (US$ Million) – by Product Type
Table 34. Italy: Europe Enteral Nutrition Market – Revenue and Forecast to 2031 (US$ Million) – by Nasogastric Type
Table 35. Italy: Europe Enteral Nutrition Market – Revenue and Forecast to 2031 (US$ Million) – by Standard By Calories
Table 36. Italy: Europe Enteral Nutrition Market – Revenue and Forecast to 2031 (US$ Million) – by Isocaloric
Table 37. Italy: Europe Enteral Nutrition Market – Revenue and Forecast to 2031 (US$ Million) – by Hypercaloric
Table 38. Italy: Europe Enteral Nutrition Market – Revenue and Forecast to 2031 (US$ Million) – by Standard By Type
Table 39. Italy: Europe Enteral Nutrition Market – Revenue and Forecast to 2031 (US$ Million) – by Standard By End User
Table 40. Spain: Europe Enteral Nutrition Market – Revenue and Forecast to 2031 (US$ Million) – by Product Type
Table 41. Spain: Europe Enteral Nutrition Market – Revenue and Forecast to 2031 (US$ Million) – by Nasogastric Type
Table 42. Spain: Europe Enteral Nutrition Market – Revenue and Forecast to 2031 (US$ Million) – by Standard By Calories
Table 43. Spain: Europe Enteral Nutrition Market – Revenue and Forecast to 2031 (US$ Million) – by Isocaloric
Table 44. Spain: Europe Enteral Nutrition Market – Revenue and Forecast to 2031 (US$ Million) – by Hypercaloric
Table 45. Spain: Europe Enteral Nutrition Market – Revenue and Forecast to 2031 (US$ Million) – by Standard By Type
Table 46. Spain: Europe Enteral Nutrition Market – Revenue and Forecast to 2031 (US$ Million) – by Standard By End User
Table 47. Czech Republic: Europe Enteral Nutrition Market – Revenue and Forecast to 2031 (US$ Million) – by Product Type
Table 48. Czech Republic: Europe Enteral Nutrition Market – Revenue and Forecast to 2031 (US$ Million) – by Nasogastric Type
Table 49. Czech Republic: Europe Enteral Nutrition Market – Revenue and Forecast to 2031 (US$ Million) – by Standard By Calories
Table 50. Czech Republic: Europe Enteral Nutrition Market – Revenue and Forecast to 2031 (US$ Million) – by Isocaloric
Table 51. Czech Republic: Europe Enteral Nutrition Market – Revenue and Forecast to 2031 (US$ Million) – by Hypercaloric
Table 52. Czech Republic: Europe Enteral Nutrition Market – Revenue and Forecast to 2031 (US$ Million) – by Standard By Type
Table 53. Czech Republic: Europe Enteral Nutrition Market – Revenue and Forecast to 2031 (US$ Million) – by Standard By End User
Table 54. Rest of Europe: Europe Enteral Nutrition Market – Revenue and Forecast to 2031 (US$ Million) – by Product Type
Table 55. Rest of Europe: Europe Enteral Nutrition Market – Revenue and Forecast to 2031 (US$ Million) – by Nasogastric Type
Table 56. Rest of Europe: Europe Enteral Nutrition Market – Revenue and Forecast to 2031 (US$ Million) – by Standard By Calories
Table 57. Rest of Europe: Europe Enteral Nutrition Market – Revenue and Forecast to 2031 (US$ Million) – by Isocaloric
Table 58. Rest of Europe: Europe Enteral Nutrition Market – Revenue and Forecast to 2031 (US$ Million) – by Hypercaloric
Table 59. Rest of Europe: Europe Enteral Nutrition Market – Revenue and Forecast to 2031 (US$ Million) – by Standard By Type
Table 60. Rest of Europe: Europe Enteral Nutrition Market – Revenue and Forecast to 2031 (US$ Million) – by Standard By End User
Table 61. Recent Organic Growth Strategies in Europe Enteral Nutrition Market
Table 62. Recent Inorganic Growth Strategies in the Europe Enteral Nutrition Market
Table 63. Glossary of Terms, Europe Enteral Nutrition Market
List of Figures
Figure 1. Europe Enteral Nutrition Market Segmentation, by Country
Figure 2. PEST Analysis
Figure 3. Impact Analysis of Drivers and Restraints
Figure 4. Europe Enteral Nutrition Market Revenue (US$ Million), 2021–2031
Figure 5. Europe Enteral Nutrition Market Share (%) – by Product Type, 2023 and 2031
Figure 6. Nasogastric: Europe Enteral Nutrition Market – Revenue and Forecast to 2031 (US$ Million)
Figure 7. Standard: Europe Enteral Nutrition Market – Revenue and Forecast to 2031 (US$ Million)
Figure 8. Disease Specific: Europe Enteral Nutrition Market – Revenue and Forecast to 2031 (US$ Million)
Figure 9. Nasoenteral: Europe Enteral Nutrition Market – Revenue and Forecast to 2031 (US$ Million)
Figure 10. Sipping: Europe Enteral Nutrition Market – Revenue and Forecast to 2031 (US$ Million)
Figure 11. Others: Europe Enteral Nutrition Market – Revenue and Forecast to 2031 (US$ Million)
Figure 12. Europe Enteral Nutrition Market Breakdown by Key Countries, 2023 and 2031 (%)
Figure 13. Germany: Europe Enteral Nutrition Market – Revenue and Forecast to 2031 (US$ Million)
Figure 14. United Kingdom: Europe Enteral Nutrition Market – Revenue and Forecast to 2031 (US$ Million)
Figure 15. France: Europe Enteral Nutrition Market – Revenue and Forecast to 2031 (US$ Million)
Figure 16. Italy: Europe Enteral Nutrition Market – Revenue and Forecast to 2031 (US$ Million)
Figure 17. Spain: Europe Enteral Nutrition Market – Revenue and Forecast to 2031 (US$ Million)
Figure 18. Czech Republic: Europe Enteral Nutrition Market – Revenue and Forecast to 2031 (US$ Million)
Figure 19. Rest of Europe: Europe Enteral Nutrition Market – Revenue and Forecast to 2031 (US$ Million)
Figure 20. Growth Strategies in Europe Enteral Nutrition Market
- Nestlé
- Danone S.A.
- Abbott Laboratories
- FrieslandCampina
- Fresenius SE and Co. KGaA
- B. Braun SE
- Dr. Schär AG
- Arla Food
- Reckitt Benckiser
- Perrigo Company PLC
- Fonterra Co-operative Group Limited
- Kate Farms
- Nutritional Medicinals, LLC
- Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the Europe enteral nutrition market.
- Highlights key business priorities in order to assist companies to realign their business strategies.
- The key findings and recommendations highlight crucial progressive industry trends in the Europe enteral nutrition market, thereby allowing players across the value chain to develop effective long-term strategies.
- Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
- Scrutinize in-depth Europe market trends and outlook coupled with the factors driving the market, as well as those hindering it.
- Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing, and distribution